Literature DB >> 19929209

The utility of rat jejunal permeability for biopharmaceutics classification system.

Parvin Zakeri-Milani1, Hadi Valizadeh, Hosnieh Tajerzadeh, Ziba Islambulchilar.   

Abstract

PURPOSE: The biopharmaceutical classification system has been developed to provide a scientific approach for classifying drug compounds based on their dose/solubility ratio and human intestinal permeability. Therefore in this study a new classification is presented, which is based on a correlation between rat and human intestinal permeability values.
METHODS: In situ technique in rat jejunum was used to determine the effective intestinal permeability of tested drugs. Then three dimensionless parameters--dose number, absorption number, and dissolution number (D(o), A(n), and D(n))--were calculated for each drug.
RESULTS: Four classes of drugs were defined, that is, class I, D(0) < 0.5, P(eff(rat)) > 5.09 x 10(-5) cm/s; class II, D(o) > 1, P(eff(rat)) > 5.09 x 10( -5) cm/s; class III, D(0) < 0.5, P(eff(rat)) < 4.2 x 10(-5) cm/s; and class IV, D(o) > 1, P(eff(rat)) < 4.2 x 10(-5) cm/s. A region of borderline drugs (0.5 < D(o) < 1, 4.2 x 10(-5) < P(eff(rat)) < 5.09 x 10(-5) cm/s) was also defined.
CONCLUSION: According to obtained results and proposed classification for drugs, it is concluded that drugs could be categorized correctly based on dose number and their intestinal permeability values in rat model using single-pass intestinal perfusion technique. This classification enables us to remark defined characteristics for intestinal absorption of all four classes using suitable cutoff points for both dose number and rat effective intestinal permeability values.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929209     DOI: 10.3109/03639040903037199

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  5 in total

Review 1.  Application of method suitability for drug permeability classification.

Authors:  Donna A Volpe
Journal:  AAPS J       Date:  2010-09-02       Impact factor: 4.009

2.  Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability.

Authors:  Badir Delf Loveymi; Mitra Jelvehgari; Parvin Zakeri-Milani; Hadi Valizadeh
Journal:  Adv Pharm Bull       Date:  2012-02-15

3.  In Vitro and In Situ evaluation of pH-dependence of atazanavir intestinal permeability and interactions with acid-reducing agents.

Authors:  Olena Kis; Sharon L Walmsley; Reina Bendayan
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

Review 4.  Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs.

Authors:  Wei Liu; Hao Pan; Caiyun Zhang; Liling Zhao; Ruixia Zhao; Yongtao Zhu; Weisan Pan
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

5.  Synthesis and Evaluation of PEG-PR for Water Flux Correction in an In Situ Rat Perfusion Model.

Authors:  Guo Chen; Xingqi Min; Qunqun Zhang; Zhiqiang Zhang; Meiqiang Wen; Jun Yang; Meijuan Zou; Wei Sun; Gang Cheng
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.